Search

Your search keyword '"Doroud, Delaram"' showing total 213 results

Search Constraints

Start Over You searched for: Author "Doroud, Delaram" Remove constraint Author: "Doroud, Delaram"
213 results on '"Doroud, Delaram"'

Search Results

5. Real-world effectiveness of the heterologous SOBERANA-02 and SOBERANA-Plus vaccine scheme in 2–11 years-old children during the SARS-CoV-2 Omicron wave in Cuba: a longitudinal case-population study

8. PastoCovac and PastoCovac Plus as protein subunit COVID-19 vaccines led to great humoral immune responses in BBIP-CorV immunized individuals

9. Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial

11. Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children

12. Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults

16. Assessment of COVID‐19 Vaccine Impact on Women's Menstrual Health within an 18‐Month Follow‐Up.

19. Immunogenicity of mannan derived from Mycobacterium bovis as a promising adjuvant in vaccine BCG.

22. Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals

24. Prevalence of Enteric Viruses in Raw Seafood Collected from the Retail Shops in Tehran, Iran, 2022–2023.

25. Potential Protectivity of a Conjugated COVID-19 Vaccine against Tetanus.

26. The impact of ABO blood types on humoral immunity responses and antibody persistency after different COVID‐19 vaccine regimens.

28. Assessment of long-term adverse events regarding different COVID-19 vaccine regimens within an 18-month follow-up study

31. Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children

32. Effect of Saponin Encapsulated by Ferritin Nanoparticles on Fetal Lung Development in Female Mice with Streptococcus pneumonia.

37. Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults

38. Corrigendum to “Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein” [Vaccine 40(20) (2022) 2856–2868]

39. Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19.

41. Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein

43. Safety and Immunogenicity of Anti-SARS-CoV-2 Conjugate Vaccine SOBERANA 02: Phase IIb Clinical Trial

45. Safety and Efficacy of the Two Doses Conjugated Protein-Based SOBERANA-02 COVID-19 Vaccine and of a Heterologous Three-Dose Combination with SOBERANA-PLUS: Double-Blind, Randomised, Placebo-Controlled Phase 3 Clinical Trial

46. Computation screening and molecular docking of FDA approved viral protease inhibitors as a potential drug against COVID-19

48. Maternal exposure during organogenesis to chlorpyrifos insecticide induce apoptosis process.

Catalog

Books, media, physical & digital resources